The Case for Mainland China Equities

I still remember the first time I ran a factor screen on the MSCI China A-share universe back in 2019. I was sitting in JOYFUL CAPITAL's Shenzhen office at 11 p.m., coffee going cold, watching the model spit out something unusual: a set of mid-cap industrial names with cash-flow yields that would make a European value manager weep. My first instinct was to distrust the data. My second instinct — the one that turned out to be right — was that the market was mispricing an entire economy. That night was, for me, the beginning of what I now consider the case for mainland China equities.

Let me set the scene for those who may be newer to this space. Mainland China equities — the A-share market, traded in Shanghai and Shenzhen, plus the Hong Kong-listed Chinese companies — represent the second-largest equity market on earth by market capitalization, yet foreign investors hold only a small single-digit percentage of it. That gap between economic weight and portfolio weight is the single most discussed anomaly in global asset allocation. The Chinese economy accounts for roughly 17-18% of global GDP, but MSCI's global index family has historically given it a weight closer to 2-4%. Something doesn't add up, and for the past several years, my team and I have been asking a simple question: is that gap a warning sign, or an opportunity?

This article is my attempt to lay out, in a structured way, why I believe mainland China equities deserve a serious, non-sentimental place in a diversified global portfolio. I'll be honest up front: this is not a cheerleading piece. There are real, non-trivial risks — regulatory, geopolitical, governance-related. But the market has a habit of pricing those risks as if they are permanent and existential, while pricing the upside as if it were fictional. That asymmetry is the heart of the case. Over the next several thousand words, I'll walk through the valuation gap, the policy pivot, the domestic demand engine, the innovation pipeline, the shareholder-return revolution, the institutional plumbing, and the behavioral forces that keep foreign capital under-allocated. Then I'll talk about what JOYFUL CAPITAL is doing about it in our own portfolio construction and AI-driven research workflows.

The Valuation Gap Is Real

Let's start with the number that keeps value investors awake at night: Chinese equities have traded at a persistent discount to global developed markets for years, and that discount has not always been justified by fundamentals. In the depths of the 2022-2024 selloff, the MSCI China Index was trading at roughly 8-10x forward earnings, versus 18-20x for the S&P 500 and 14-16x for MSCI Europe. Even after the 2024-2025 recovery, the gap remains historically wide. That is not a rounding error; it's a structural mispricing in my view.

Now, I want to be careful here. A low multiple can be a value trap, and anyone who has been in this market for a decade knows the pain of "cheap for a reason." The bears will tell you the discount reflects governance risk, geopolitical risk, and the possibility of capital controls. That's fair. But when you decompose the discount, a lot of it is explained by index composition and narrative momentum, not by deteriorating earnings. A large share of the MSCI China benchmark is made up of platform companies, banks, and state-owned enterprises that trade at deep discounts to Western peers despite comparable returns on capital. Meanwhile, the Chinese market has a much higher concentration of new-economy sectors — EV, battery, solar, e-commerce, biotech — than its index weight suggests.

I'll give you a concrete example from our own work at JOYFUL CAPITAL. In mid-2023, our AI screening pipeline flagged a cluster of A-share battery-materials companies trading at 6-8x forward earnings with 20%+ growth rates. On paper, that looked like a data error. We dug in, spoke with supply-chain experts, and concluded that the market was applying a "commodity-cycle peak" framework to businesses that had already moved down the cost curve. We initiated a small position through HK-listed proxies for liquidity reasons. It wasn't a home run, but it taught me that the discount was, at least in part, a function of misapplied Western heuristics rather than genuine value destruction.

Here's the thing that I think gets lost in the noise: the Chinese market is not one market. Onshore A-shares, offshore H-shares, and US-listed ADRs trade at different multiples, with different investor bases, and with different liquidity profiles. The H-share discount to A-shares has narrowed and widened over the years, creating relative-value opportunities that are all but invisible to a benchmark-hugging global manager. For a data-driven shop like ours, that fragmentation is not a bug — it's the whole point.

So when I say "the valuation gap is real," I don't mean it's free money. I mean it's a persistent, measurable, and — crucially — decomposable mispricing. Some of it is risk. Some of it is composition. Some of it is narrative. And the parts that are narrative are the parts that can change quickly, and they are the parts we try to underwrite.

The Policy Pivot Has Landed

For much of 2021-2023, the dominant narrative was that Beijing had turned against its own private sector — the "common prosperity" campaign, the platform-company crackdown, the property deleveraging. I'm not going to pretend those were fun years to be long Chinese equities. But what matters for investors is not the past policy stance; it's the direction of travel, and the direction since late 2024 has been unmistakably pro-market, or at least less anti-market.

The September 2024 policy package was, in my view, a genuine turning point. The People's Bank of China rolled out rate cuts and liquidity support, the Politburo explicitly acknowledged the need to stabilize the property market, and regulators signaled that the worst of the platform-company regulatory cycle was over. Since then, we've seen a steady drumbeat of measures: swap facilities for brokers and insurers, buyback incentives for listed companies, and a broad relaxation of real-estate purchase restrictions in tier-1 cities. This is not a 2008-style bazooka, and it's not meant to be. It's a careful, calibrated pivot.

Why does that matter for equity investors? Two reasons. First, policy uncertainty is itself a risk premium. When investors don't know whether the government will nationalize an entire sector tomorrow, they demand a higher discount rate. When that uncertainty starts to decline, the discount rate falls, and multiples re-rate. Second, the policy pivot is being accompanied by a genuine shift in the composition of growth — away from property and infrastructure, toward advanced manufacturing and services. That shift is messy, but it's also the source of the next decade's earnings growth.

I recall a call with a Beijing-based policy consultant in late 2024. He said something that stuck with me: "The government has realized that confidence is the binding constraint, not capital." That's a subtle but important reframing. For years, the assumption was that the problem was lack of demand, and the solution was stimulus. But the real problem was that households and firms were sitting on cash because they didn't trust the future. Policy now, at least in part, is aimed at rebuilding that trust — through property stabilization, through explicit support for private entrepreneurs, through signals that regulation will be predictable rather than capricious.

Now, I'm not naive. The policy pivot could stall. Local government financing vehicles are still under stress, and the property sector is not out of the woods. But the direction of the pivot is what matters for equity pricing, and for the first time in several years, the direction is favorable.

Domestic Demand Is Underrated

Western commentary on China often reduces the economy to exports and property. Both matter, but both miss the point. The Chinese consumer — 1.4 billion people, a rising middle class, and an urbanization rate still below 70% — is the story that foreign investors chronically underestimate. I say this not as a cheerleader but as someone who has pored over consumer credit data, mobility data, and e-commerce transaction data for years.

Take services consumption. It has been growing faster than goods consumption for several years, and it's far less well-captured in the standard macroeconomic data that foreign analysts rely on. Because a lot of Chinese consumption is digital-native — platform-based food delivery, live-stream shopping, travel booking inside super-apps — the official statistics lag the reality. Our own alternative datasets, which we've built at JOYFUL CAPITAL using aggregated card and app data, consistently show services demand recovering faster than the headline retail sales figures suggest.

There's another dimension: the savings overhang. Chinese households hold a very high savings rate, much of it in bank deposits earning near-zero real returns. As deposit rates come down and confidence slowly returns, even a small reallocation of that stock of savings into equities or consumption would be a massive tailwind. This is not a forecast; it's an option that the market is pricing at close to zero.

I'll be candid: I've been early on the Chinese consumer trade more than once. In 2023, I argued internally that the post-reopening consumption boom would be stronger than consensus. It wasn't — households remained cautious. That was a useful lesson in humility. But being early is not the same as being wrong, and the structural drivers — income growth, urbanization, services penetration — remain intact. The mistake that many made was to extrapolate a post-COVID savings spike into a permanent behavioral shift. I think the more likely path is a gradual normalization, and as it happens, it will surprise to the upside.

For a global portfolio, the Chinese consumer offers something increasingly rare: a large, under-penetrated demand pool that is not highly correlated with Western business cycles. That diversification value alone justifies a closer look.

Innovation Is Not a Western Monopoly

One of the most persistent myths in global investing is that China can copy but cannot innovate. Anyone who has spent time in Shenzhen or Hefei or Shanghai knows this is nonsense. The Chinese EV and battery complex is arguably the most advanced in the world. CATL, BYD, and a dozen smaller players have built supply chains that Western automakers are scrambling to replicate. In solar, China controls the overwhelming majority of global polysilicon and wafer capacity. In biotech, licensing deals from Chinese biotechs to Western pharma have exploded, with deal values in the tens of billions of dollars annually.

At JOYFUL CAPITAL, we use a combination of patent data, supply-chain mapping, and technical hiring data to track innovation clusters. One of our models flagged a mid-cap A-share medical-device company in 2023 that had quietly accumulated a portfolio of interventional cardiology patents and was expanding into Southeast Asia. The sell-side coverage was thin, the English-language research was almost nonexistent, and the stock was trading at a fraction of its global peers. That's the kind of asymmetry that a purely benchmark-driven approach will never capture.

I should add that China's innovation model is not identical to Silicon Valley's. It's more applied, more manufacturing-centric, and more tightly linked to state industrial policy. That has pluses and minuses. The plus is speed and scale — China can commercialize a technology at a pace the West struggles to match. The minus is that capital allocation can be distorted by local-government competition, leading to overcapacity in some sectors (solar being a recent example).

For equity investors, the key point is that the innovation pipeline is real and it's investable. You don't get exposure to it by buying the MSCI China benchmark, which is still dominated by financials and platforms. You get it by doing the hard work of bottom-up research, which is exactly where active management can earn its fee.

There's a broader point here about AI. Chinese AI companies may be constrained on the most advanced chips, but they are extremely strong in application-layer AI, computer vision, and industrial automation. In our own AI-driven research at JOYFUL CAPITAL, we've found that Chinese-language NLP models — many of them open-source — are competitive with Western models on domain-specific tasks. That's not just a tech story; it's an earnings story for the companies deploying those models in manufacturing, logistics, and healthcare.

Shareholder Returns Are Changing

For years, one of the strongest arguments against Chinese equities was that companies didn't return cash to shareholders. Dividends were low, buybacks were rare, and capital allocation was often driven by state priorities rather than investor returns. That is changing, and I think the change is structural, not cyclical.

Since 2023, regulators have been pushing listed companies — especially state-owned enterprises — to increase dividends and buybacks. The results have been striking. Dividend payout ratios for large SOEs have risen meaningfully, and buyback announcements have hit record levels. For a value investor, this matters enormously: it converts "cheap" from a theoretical statement into a tangible cash return. When a company trading at 5x earnings starts paying out 5-6% dividend yields and buying back stock, the math starts working even if the multiple never re-rates.

We've seen this in our own portfolios. One of our A-share holdings, a large state-owned infrastructure company, went from a 30% payout ratio to over 60% in two years. That single change transformed the stock from a value trap into a respectable total-return story. I won't pretend we saw it coming perfectly — we didn't — but our screening for rising payout ratios flagged it early, and that's a repeatable process.

The buyback story is even more interesting because it's newer. Buybacks have historically been constrained by Chinese corporate law and by a culture that favored reinvestment. But the 2023-2024 regulatory reforms made buybacks easier and more tax-efficient, and companies have responded. In 2024, buyback announcements hit record highs, and the trend has continued into 2025.

What does this mean for valuation? It means the cash-return yield on Chinese equities is rising, and that yield is a much more reliable anchor than a forward P/E multiple. In a world where global bond yields are volatile and equity risk premiums are compressed, a market offering 5-7% cash returns with modest growth is genuinely attractive. I think this is one of the most under-appreciated changes in the Chinese equity story.

Institutional Plumbing Is Improving

A less glamorous but critically important part of the case is the steady improvement in market infrastructure. When I started covering China, the complaints were legion: capital controls, opaque disclosure, weak minority-shareholder protections, and limited hedging tools. Many of those complaints are still valid to some degree, but the direction of change is positive.

Stock Connect, the pipeline that allows foreign investors to trade A-shares through Hong Kong, has been expanded repeatedly. The scope of eligible stocks has widened, trading hours have been extended, and the daily quota has been effectively removed. For a foreign institutional investor, this is a game-changer: you can now build and liquidate meaningful positions in A-shares without the operational headaches of the old QFII/RQFII regime.

Disclosure has also improved. Chinese listed companies now file more detailed ESG reports, and the quality of English-language disclosure has risen, though it's still uneven. The regulators have cracked down on fraud and insider trading, though enforcement remains inconsistent. I'd say the plumbing is now "good enough" for most institutional investors, whereas a decade ago it wasn't.

There's also a growing domestic institutional base — pension funds, insurance companies, and mutual funds — that is slowly shifting its allocation toward equities. This is important because it reduces the market's historical dependence on retail sentiment and creates a more stable buyer base. The Chinese pension system is still young, but its assets are growing fast, and even a modest equity allocation shift would be significant.

From a data-strategy perspective, I'll add one more point: the quality and availability of Chinese financial data have improved dramatically. Ten years ago, getting clean A-share fundamentals required expensive vendors and a lot of manual work. Now, APIs and standardized datasets are widely available, and alternative data — satellite, card, app — is increasingly accessible. For an AI-driven shop like JOYFUL CAPITAL, that's a huge enabler.

Behavioral Under-Allocation Persists

Finally, I want to talk about the behavioral side, because I think it's the most powerful and least discussed part of the case. Global investors are systematically under-allocated to China, and that under-allocation is driven as much by psychology as by fundamentals.

There's a well-documented home-bias effect in investing: people prefer to invest in what they know. For Western allocators, China is distant, linguistically challenging, and politically unfamiliar. Add to that a relentless negative media narrative — headlines about property defaults, regulatory crackdowns, and geopolitical tension — and you get a powerful emotional deterrent. I've sat in meetings where a CIO said, essentially, "I don't need the headache." That's a real sentiment, and it has real portfolio consequences.

But here's the thing: under-allocation creates opportunity for those willing to do the work. If everyone already owned Chinese equities at their economic weight, the valuation gap wouldn't exist. The gap exists precisely because most investors have emotionally opted out. That's the essence of a contrarian opportunity, and it's the kind of setup that has historically rewarded patient capital.

I'll share a personal anecdote. In early 2024, I presented our China thesis to an external investment committee. The response was polite but skeptical. One member asked, "Why would we take geopolitical risk for a market that has underperformed for a decade?" It was a fair question, and I didn't have a perfect answer. What I said was this: "The market has already priced a lot of bad outcomes. The question is whether it has priced the good ones." A year later, that committee has warmed up considerably.

The behavioral point cuts both ways, of course. Sentiment can stay negative for a long time, and being early can be expensive. But for long-horizon investors — pensions, sovereign funds, family offices — the math is compelling. The marginal buyer of Chinese equities over the next decade is likely to be domestic institutions and a small number of global contrarians. That's a favorable supply-demand setup.

Where JOYFUL CAPITAL Stands

At JOYFUL CAPITAL, our approach to mainland China equities is neither a blanket endorsement nor a blanket avoidance. We treat it as a distinct, diversified opportunity set that requires its own research infrastructure, its own risk framework, and its own data pipeline. Our AI-driven research platform ingests A-share, H-share, and ADR data side by side, normalizes accounting differences, and surfaces relative-value signals across the three markets. We pair that with on-the-ground channel checks and a network of local experts, because quantitative signals alone are not enough in a market where policy and narrative can move prices violently.

The biggest challenge we've encountered is not finding cheap stocks — there are plenty — but distinguishing between cheap for a reason and cheap because of a mispricing. That requires judgment, and judgment requires context. We've built internal "policy risk scores" for sectors, and we overlay those on our valuation models. It's imperfect, but it's better than ignoring the issue. My personal view is that the next decade of alpha in China will come from firms that combine rigorous data science with genuine local understanding, and that's exactly the bet we're making.

We also think about China not as a standalone allocation but as part of a broader emerging-market and global portfolio. Correlation matters. Chinese equities have historically had relatively low correlation with US equities, which makes them valuable diversifiers even if their standalone Sharpe ratio is unimpressive. In a world of higher inflation and geopolitical fragmentation, that diversification value is not a nice-to-have; it's a strategic necessity.

Looking forward, I expect the market to remain volatile and the narrative to remain noisy. But I also expect the structural case — valuation, policy, innovation, shareholder returns, institutional plumbing, and behavioral under-allocation — to grind higher. The case for mainland China equities is not a one-year trade; it's a ten-year thesis. And for investors with the patience and the analytical infrastructure to pursue it, the opportunity is, in my view, one of the most compelling in global markets today.

As for JOYFUL CAPITAL's own insight: our experience is that mainland China equities are best approached as a data-rich, narrative-poor asset class. The data is abundant and increasingly high-quality; the narratives are distorted by politics and emotion. Our edge comes from systematically extracting signals from the data while maintaining a clear-eyed view of the real risks. We don't pretend to predict policy, but we do try to quantify its likely range of outcomes and price them accordingly. The result, we believe, is a portfolio that captures the upside of China's structural story while respecting the genuine uncertainties. For allocators willing to do the same, the case for mainland China equities is not just defensible — it's compelling.